Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT00973739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 2
Vestibular Schwannoma

Interventions

DRUG: Lapatinib

Sponsor

NYU Langone Health

Collaborators

[object Object]